1 hr ago
Metropolis Healthcare targets technology-led growth amid local consolidation
Metropolis Healthcare runs laboratories and sample-collection centres for medical tests.
The company says the diagnostics industry has become more stable after several difficult years.
It wants to spend the next few years strengthening its existing network instead of rapidly adding new laboratories.
It will add more collection centres in towns.
Metropolis hopes to increase its yearly revenue to more than ₹2,500 crore in about three years.
The company also plans to use more technology and artificial intelligence.
These tools are expected to make work faster and more efficient.
Management said some jobs may not be refilled when employees leave, while the business continues to grow.
The company says this approach will help it expand without pushing products unnecessarily.
Metropolis Healthcare plans to consolidate its local presence while continuing organic network expansion.
The company aims to exceed ₹2,500 crore in revenue within about three years.
Metropolis has 209 laboratories and more than 5,000 centres across 750 towns.
The company plans to automate processes and use AI to improve productivity, workflows and turnaround times.
Management said selective inorganic growth and deeper penetration into towns will remain priorities.
- Who
- Metropolis Healthcare, its promoter and Executive Chairperson Ameera Shah, and Managing Director Surendran Chemmenkotil.
- What
- The diagnostic chain is consolidating its local presence, expanding its network and transforming operations through technology and AI.
- Where
- Metropolis operates across 750 towns and in countries in Africa.
- When
- The consolidation phase is planned for FY26 to FY29, with the revenue target expected in about three years. The article was published on September 5, 2026.
- Why
- Management says greater industry stability creates an opportunity to strengthen the business, improve productivity and accelerate organic growth.
Key facts
- Current revenue
- About ₹1,650 crore
- Revenue target
- More than ₹2,500 crore in about three years
- Laboratories
- 209
- Collection centres
- More than 5,000
- Geographic reach
- 750 towns and countries in Africa
- Industry size
- About $11 billion currently, projected to reach $28.5 billion by 2034
- Organised market share
- About 15 per cent of the overall diagnostics market
Quotes
Ameera Shah
Metropolis Healthcare promoter and executive chairperson
“FY26 to FY29 is a period of consolidation. And while we continue to expand, obviously, the organic growth will be even faster, consolidation from a perspective of no lab expansion, but really accelerating our collection centres.”
thehindubusinessline.com
“There is a sense of more stability in the industry. And now there is a sense of confidence to say, ‘Look, we can build even stronger from here’.”
thehindubusinessline.com
Surendran Chemmenkotil
Metropolis Healthcare managing director
“Metropolis will completely transform into a technology company in the next two to three years period.”
thehindubusinessline.com
Sources
Related news
Lord's Mark Industries Unveils ₹1,550 Crore Healthcare Expansion Plan
India Health 2026 Highlights India’s Growing Medtech Manufacturing Base
KKR to Acquire Medicover Hospital Network for $1.4 Billion
Lord’s Mark Plans Healthcare Expansion, Revenue Growth and Energy Demerger
India's hidden healthcare tech stock bets big on TruBridge
Preventive Health Checks Gain Ground Across India’s Diagnostic Industry
JM Financial Sees 25-35% Upside in Three Buy Stocks
Insulin Resistance: A Growing Metabolic Health Crisis in India
Metropolis Healthcare Launches Centre of Genomics
